PurePRP®II GenesisCS Component Concentrating System
Providing the next generation
of regenerative therapies.
Call us today at
(877) 887-3436
We are a distributor of amnion-derived products and other medical solutions to physicians, surgeons, clinics, and hospitals.
PurePRP®II GenesisCS Component Concentrating System
PurePRP® II is an autologous cellular biologic that has become standard of care for many treatment modalities. In today’s world fo regenerative medicine, clinicians are requiring products that are not only clinically effective but also have the versatility to provide for specific treatment requirements. This may include therapeutic strength PRP with high neutrophils and nominal red blood cells. Some physicians may require a bioregenerative fibrinogen matrix scaffold to support PRP retention and sustain growth factor release. Others may require protein compositions to help mitigate cellular degradation. Whatever the need, PurePRP® II has the biologic versatility to be an integral part of the treatment modality.
One System Two Protocols
Protocol A
Protocol A processes PurePRP® without red blood cells or neutrophil granulocytes. This protocol is used when powerful healing without inflammatory activity is required at the application site. This protocol is also the low viscosity solution to a viable PRP product, providing very high concentrations of platelets in a bath of non-viscous plasma. This protocol has also been reported to reduce the potential for pain at the application site. It is the most frequently used protocol.
Low Inflammatory PRP
- High Platelet Count
- Low Granulocyte
- Low Viscosity
- Less than 1% HCT
Protocol B
Protocol B processes PurePRP® with low red blood cell counts and very high cytokine activity and neutrophil cell recoveries. This protocol is used when the phagocytic powers of neutrophils are needed to help fight infectious processes at the application site. This protocol produces the highest chemoattractant activity and significantly increases regeneration potential. Once the neutrophils have completed phagocytosis, they become apoptic cells and are subsequently removed, thereby also eliminating the inflammatory activity.
Infection Fighting PRP with Increased Cytokines
- Higher Platelet Count
- High Neutrophil Granulocytes
- Moderate Viscosity
- HCT Less than 20%
Features and Benefits
- PurePRP® II is unique in that it greatly enhances monocyte concentrations, while giving the end user control over the amount of neutrophils they would like to add to their PRP preparation. PurePRP® II takes advantage of the long term phagocytic and protective properties of the monocytes while avoiding the potential harmful inflammation incurred by large concentrations of neutrophils that go through cellular necrosis. This is another differentiating factor that help to explain the natural success of PurePRP® II in patient outcomes.
Call us today at
(877) 887-3436
REGENISOURCE PROVIDES THE NEXT GENERATION OF REGENERATIVE THERAPIES.
TESTIMONIALS
“My knee injections with amnio did exceptionally well for me, even letting me return in to competitive cycling. I put 1000 miles on my racing bike last year, only 6 months after my amnio injections.”
“In my 7 years using human placental tissue allografts patients experienced a more rapid recovery time than conventional standard of care treatments. Patients and I noted a significant decrease in inflammation/ swelling which reduces pain and increases function. Unlike cortisone which has a long list of side effects, no adverse events have ever been reported using these placental tissue allograft.”